Laddar...
Treatment of walking impairment in multiple sclerosis with dalfampridine
Potassium channel blockade has long been considered a potential therapeutic strategy for treatment of multiple sclerosis (MS) based on the pathophysiology of demyelinated axons. Dalfampridine, which is also known as fampridine or 4-aminopyridine (4-AP), is the potassium channel blocker that has been...
Sparad:
| Huvudupphovsman: | |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
SAGE Publishing
2011-03-01
|
| Serie: | Therapeutic Advances in Neurological Disorders |
| Länkar: | https://doi.org/10.1177/1756285611403960 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|